ATLANTA—Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university’s Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.
OVER THE LAST SEVERAL YEARS, Georgia State has garnered national recognition for improving student success regardless of background and exponentially raising graduation rates. Now it is developing a national reputation as one of the country’s fastest growing research universities.
Twenty-one years ago, Georgia State was named a research university by the Carnegie Classification of Institutions of Higher Education, setting the university on a trajectory to become a premier urban public research university.
ATLANTA—Dr. Chris Basler, a world-renowned research leader in the study of emerging viruses, including the Ebola virus, has been named founding director of the Center for Microbial Pathogenesis, Institute for Biomedical Sciences (IBMS), at Georgia State University.